Understanding how cell processes manage protein balance in neurons from Parkinson's disease patients.

The role of ER-phagy in maintaining protein homeostasis in PD patient derived neurons.

NIH-funded research Northwestern University at Chicago · NIH-11001963

This study is looking at how brain cells from people with Parkinson's disease manage proteins, especially one called alpha-synuclein, to understand how problems in this process might affect the disease and help find better treatments.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionNorthwestern University at Chicago NIH-funded
Lab location1 site (Chicago, United States)
Project IDNIH-11001963 on NIH RePORTER

What this research studies

This research investigates the mechanisms by which neurons derived from patients with Parkinson's disease maintain protein balance, particularly focusing on the role of a protein called alpha-synuclein. The study utilizes neurons created from induced pluripotent stem cells (iPSCs) to observe how these cells handle misfolded proteins and the impact of genetic factors on this process. By examining the autophagy-lysosomal pathway, the research aims to uncover how disruptions in these cellular processes contribute to the progression of Parkinson's disease. Patients may be involved in providing iPSCs for the study, which could lead to insights into personalized treatment approaches.

Who could benefit from this research

Good fit: Ideal candidates for participation are individuals diagnosed with Parkinson's disease, particularly those with genetic mutations related to the condition.

Not a fit: Patients without a diagnosis of Parkinson's disease or those with unrelated neurodegenerative conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating or managing Parkinson's disease by improving protein homeostasis in affected neurons.

How similar studies have performed: Previous research has shown promising results in understanding protein homeostasis in neurodegenerative diseases, indicating that this approach may yield valuable insights.

Where this research is happening

Chicago, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions age associated neurodegenerative diseaseage associated neurodegenerative disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.